Mode of action of a staphylococcal anti-inflammatory factor.
D000818:Animals; D000893:Anti-Inflammatory Agents; D001426:Bacterial Proteins / Q000494:pharmacology*; D001578:Benzopyrans; D001593:Benzyl Compounds / Q000494:pharmacology; D002860:Chromium Radioisotopes; D004912:Erythrocytes; D005029:Ethylenediamines / Q000494:pharmacology; D005174:Factor XII; D006168:Guinea Pigs; D006461:Hemolysis; D006634:Histamine H1 Antagonists; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007705:Kinins / Q000037:antagonists & inhibitors; D009088:Mucoproteins / Q000494:pharmacology*; D011479:Protamines / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D013210:Staphylococcus; D014050:Toluene / Q000494:pharmacology; D062367:ortho-Aminobenzoates / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D001426:Bacterial Proteins; D001578:Benzopyrans; D001593:Benzyl Compounds; D002860:Chromium Radioisotopes; D005029:Ethylenediamines; D006634:Histamine H1 Antagonists; D007705:Kinins; D009088:Mucoproteins; D011479:Protamines; D011725:Pyridines; D062367:ortho-Aminobenzoates; D014050:Toluene; D005174:Factor XII